Home > Boards > US Listed > Medical - Drugs > Menlo Therapeutics Inc. (MNLO) (MNLO)

Insiders had their options moved forward.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
realfast95 Member Profile
Member Level 
Followed By 48
Posts 14,682
Boards Moderated 1
Alias Born 11/29/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 1:35:38 PM
Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement Business Wire - 5/22/2020 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2020 8:04:15 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 7:09:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:55:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:55:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:55:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:54:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:54:15 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/7/2020 5:28:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2020 4:31:08 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/16/2020 12:47:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/10/2020 4:01:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:24:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:23:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:23:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:22:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:22:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:22:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:20:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 9:00:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:48:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:42:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:42:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:33:49 PM
realfast95 Member Level  Sunday, 12/15/19 11:25:51 AM
Re: None
Post # of 316 
Insiders had their options moved forward.


(1) On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, ("RSUs"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code.


Chief Scientific Officer
12/11/2019 M 80300
12/11/2019 F 27766 D $4.52


General Counsel and Chief Compliance Officer
12/11/2019 M 24090 A
12/11/2019 F 8271 D $4.52

Senior Vice President, Corporate Strategy and Chief Financial Officer
12/11/2019 M 80300 A
12/11/2019 F 27766 D $4.52

Chief Executive Officer
12/11/2019 M 238800 A
12/11/2019 F 85210 D $4.52
12/11/2019 M 14000 A $1.83

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist